A sleep laboratory in Kolkata is campaigning to normalize insurance coverage for Obstructive Sleep Apnea (OSA), a common but ...

A recent study has found a surprising connection between sleep-related breathing problems and changes in the brain. Published ...

The FDA on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug ...

Sleep issues are common with an autism diagnosis. Studies suggest that well over half of all autistic people, adults as well as children, have significant sleep issues. These sleep issues can be ...

A recent study links sleep deprivation to mental health issues, focusing on how poor sleep impacts brain regions that control ...

"Zepbound is the first medication that significantly improves moderate-to-severe OSA and aids in long-term weight loss in ...

For patients who have long struggled with insomnia, remission after treatment can feel anxiety-provoking. Learn practical ...

New Guideline Provides Treatment Recommendations for ... use by preschool-age children can lead to reduced sleep quality, exacerbating problems such as poor attention, hyperactivity and unstable ...

Those who suffer from seasonal affective disorder, a form of depression that's closely linked to the circadian rhythms that govern our sleep ... The U.S. Food and Drug Administration (FDA ...

Symptoms such as changes in sleep patterns can begin in the ... you to change your dose or to find another bipolar disorder medication or treatment. It may take several tries before you find ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...